Lovin’ Lumos!
In today’s episode of Trading Up, Colin explains why shares of biotech stock Lumos Diagnostic surged 563 per cent on the back of FDA approval.
Plus, Bill Beament’s Develop Global lobs bid for lithium junior Essential Metals and the biggest IPO of the year Redox slips into the red.
WATCH THE LATEST EPISODE IN THE VIDEO PLAYER ABOVE
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Business News Click Here